HIV, Late presentation, Microbiota, Antiretroviral therapy, dolutegravir
HIV, Late presentation, microbiota, antiretroviral therapy, Dolutegravir
Late HIV presentation, cardiovascular disease, myocardial infarction, cerebrovascular disease, HIV.
HIV, late presenters, delayed HIV diagnosis, Immune recovery, Immune response, Integrase inhibitors, Mortality.
People with HIV, Cardiovascular risk, Vasa vasorum density, contrast-enhanced carotid ultrasound, Atherosclerosis
